Richard E. Kuntz, M.D., M.Sc.
Board Member
DiaMedica Therapeutics Inc. (DMAC)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Richard E. Kuntz, M.D., M.Sc.
Richard E. Kuntz, M.D., M.Sc. is recorded as Board Member at DiaMedica Therapeutics Inc. (DMAC). DiaMedica Therapeutics Inc. reported in an 8-K filed May 30, 2023 that Richard E. Kuntz, M.D., M.Sc. was appointed Board of Directors, effective May 30, 2023.
“On May 30, 2023, the Board of Directors (the "Board") of DiaMedica Therapeutics Inc. (the "Company"), upon recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Richard E. Kuntz, M.D., M.Sc. to the Board, effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-05-30–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at DiaMedica Therapeutics Inc.
Other people whose current roles at this company are on record from its filings.
- Rick Pauls CEO, Board Member
- James Parsons Chairman
- Charles Semba Board Member
- Charles Semba, M.D. Board Member
- Daniel J. O'Connor Board Member
- Daniel O’Connor Board Member
- Michael Giuffre Board Member
- Michael Giuffre, M.D. Board Member
- Richard Kuntz Board Member
- Richard Kuntz, M.D., M.Sc. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.